Why Co-Diagnostics Stock Slipped Today

·2 min read

An analyst price target cut was the impetus behind Co-Diagnostics' (NASDAQ: CODX) share price drop on Monday. The biotech's stock lost nearly 4% of its value that day; what didn't help was that the cut was preceded by a recommendation downgrade from a different prognosticator. Co-Diagnostics is now worth $9 per share, in the estimation of H.C. Wainwright's Raghuram Selvaraju.